- Home
- FSEA vs ALGS Comparison
FSEA vs ALGS Comparison
Compare FSEA & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- ALGS
- Stock Information
- Founded
- FSEA 1890
- ALGS 2018
- Country
- FSEA United States
- ALGS United States
- Employees
- FSEA N/A
- ALGS N/A
- Industry
- FSEA Savings Institutions
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- ALGS Health Care
- Exchange
- FSEA Nasdaq
- ALGS Nasdaq
- Market Cap
- FSEA 52.8M
- ALGS 53.0M
- IPO Year
- FSEA N/A
- ALGS 2020
- Fundamental
- Price
- FSEA $11.51
- ALGS $9.13
- Analyst Decision
- FSEA
- ALGS Strong Buy
- Analyst Count
- FSEA 0
- ALGS 1
- Target Price
- FSEA N/A
- ALGS $70.00
- AVG Volume (30 Days)
- FSEA 4.0K
- ALGS 85.7K
- Earning Date
- FSEA 08-08-2025
- ALGS 08-05-2025
- Dividend Yield
- FSEA N/A
- ALGS N/A
- EPS Growth
- FSEA N/A
- ALGS N/A
- EPS
- FSEA 0.00
- ALGS N/A
- Revenue
- FSEA $16,196,000.00
- ALGS $3,270,000.00
- Revenue This Year
- FSEA N/A
- ALGS N/A
- Revenue Next Year
- FSEA N/A
- ALGS $51.55
- P/E Ratio
- FSEA $1,512.58
- ALGS N/A
- Revenue Growth
- FSEA 97.61
- ALGS N/A
- 52 Week Low
- FSEA $8.90
- ALGS $3.76
- 52 Week High
- FSEA $11.80
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- FSEA 57.13
- ALGS 59.79
- Support Level
- FSEA $11.18
- ALGS $8.18
- Resistance Level
- FSEA $11.75
- ALGS $9.44
- Average True Range (ATR)
- FSEA 0.20
- ALGS 0.71
- MACD
- FSEA 0.03
- ALGS 0.01
- Stochastic Oscillator
- FSEA 67.18
- ALGS 65.95
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.